Loading…

Population Pharmacokinetics of Inotuzumab Ozogamicin (InO) As Single Agent in Pediatric Relapsed/Refractory Acute Lymphoblastic Leukemia - Results from the ITCC-059 Phase IA and Phase II Trial

Saved in:

Bibliographic Details
Published in:	Blood 2022-11, Vol.140 (Supplement 1), p.8845-8847
Main Authors:	Pennesi, Edoardo, Brivio, Erica, Pelletier, Kathleen B., Chen, Ying, Huitema, Alwin D.R., Jiang, Yilin, Ammerlaan, Anneke C.J., Sleight, Barbara, Locatelli, Franco, Van Der Sluis, Inge M., Rossig, Claudia, Chen-Santel, Christiane, Bielorai, Bella, Petit, Arnaud, Stary, Jan, Sramkova, Lucie, Díaz de Heredia Rubio, Cristina, Rives, Susana, O'Marcaigh, Aengus, Rizzari, Carmelo, Engstler, Gernot, Nysom, Karsten, Rubio-San-Simón, Alba, Bautista Sirvent, Francisco J., Bruno, Bénédicte, Bertrand, Yives, Brethon, Benoit, Rialland, Fanny, Plat, Genevieve, Dirksen, Uta, Garrett, May, Zwaan, Christian M.
Format:	Article
Language:	English
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!